Artal Group S.A. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2020$3,375,000
-64.6%
500,000
-66.7%
0.09%
-76.7%
Q1 2020$9,540,000
-47.7%
1,500,000
-14.3%
0.40%
-42.8%
Q4 2019$18,244,000
+828.4%
1,750,000
+250.0%
0.70%
+792.4%
Q3 2019$1,965,000
-45.3%
500,000
+150.0%
0.08%
-40.6%
Q4 2018$3,592,000
-21.0%
200,000
+100.0%
0.13%
+37.1%
Q2 2018$4,547,000
-65.6%
100,000
-60.0%
0.10%
-41.2%
Q1 2018$13,200,000
-22.4%
250,0000.0%0.16%
-35.8%
Q4 2017$17,000,000
+79.4%
250,000
+117.4%
0.26%
+57.7%
Q3 2017$9,476,000
+304.8%
115,000
+360.0%
0.16%
+297.6%
Q2 2017$2,341,000
+5.4%
25,000
-50.0%
0.04%
-16.3%
Q4 2016$2,221,00050,0000.05%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders